U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07302698) titled 'PK and Onset of Hezkue Oral Sildenafil Suspension After Alcohol Consumption' on Dec. 11.
Brief Summary: This is an open-label, randomized study evaluating the pharmacokinetics and onset performance of Hezkue(R) oral sildenafil suspension administered following moderate alcohol consumption in healthy adult subjects. Participants will receive Hezkue(R) under controlled alcohol-exposure conditions. Pharmacokinetic sampling, onset assessments, and safety evaluations will be conducted throughout the study.
Study Start Date: March 15, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: Hezkue Oral Silde...